Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer

Background This ancillary study aimed to evaluate 18 F-FDG PET parameter changes after one cycle of treatment compared to baseline in patients receiving first-line neoadjuvant anti-angiogenic nintedanib combined to paclitaxel-carboplatin chemotherapy or chemotherapy plus placebo and to evaluate the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of nuclear medicine and molecular imaging 2021-06, Vol.48 (6), p.1998-2008
Hauptverfasser:	Aide, Nicolas, Fauchille, Pauline, Coquan, Elodie, Ferron, Gwenael, Combe, Pierre, Meunier, Jérome, Alexandre, Jerôme, Berton, Dominique, Leary, Alexandra, De Rauglaudre, Gaétan, Bonichon, Nathalie, Pujade Lauraine, Eric, Joly, Florence
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Antiangiogenics Cancer Carboplatin Cardiology Chemotherapy Clinical trials Correlation Criteria Evaluation Fluorine isotopes Glycolysis Imaging Medicine Medicine & Public Health Metabolic disorders Metabolic response Nuclear Medicine Oncology Oncology – Genitourinary Original Original Article Orthopedics Ovarian cancer Paclitaxel Parameters Patients Placebos Positron emission tomography Radiology Statistical analysis Surgery Survival Tumor markers Tumors Variation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!